Residual Inhibition of 40 Hz Burst Sound in Tinnitus Patients
Key facts
- Who runs it
- Eye & ENT Hospital of Fudan University
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 363 people enrolled
- Started
- 28 Oct 2024
- Ended
- 11 Feb 2026
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Personalized 40 Hz Broadband Stimulation
- 40 Hz Pure Tone Stimulation
- Continuous Broadband Noise
- Record updated
- 27 October 2026
Who can take part
- Age
- 18 years to 70 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (14)Hide the full registry criteria
Who can take part
- Diagnosed with subjective tinnitus
- Chronic tinnitus: tinnitus course ≥ 1 month
- Normal middle ear function
- The average hearing threshold (defined as mean of 0.5, 1, 2, and 4 kHz) of the unaffected ear < 60 dB
- Tinnitus can be heard under normal circumstances
- Subjects are able to understand the purpose of the study, volunteer to participate and cooperate with the instructors to complete the experiment, and be willing to sign the informed consent
Who cannot take part
- Severe psychiatric disorders
- Acute phase tinnitus
- Fluctuating tinnitus loudness
- Inability to complete tinnitus testing
- Fluctuating or retrocochlear hearing loss
- Conductive hearing loss
- Currently participating in other research projects that may affect tinnitus
- Subjects who are not considered suitable for this clinical trial by the researchers
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Tinnitus affects 10-15% of adults and is frequently associated with impaired quality of life, anxiety, and sleep disturbance. Conventional sound therapies based on continuous masking provide inconsistent and short-lived relief, and the neural mechanisms underlying residual inhibition (RI) remain unclear.
Read full original descriptionShow less
This study aims to determine whether 40 Hz burst stimulation with high-frequency carriers can achieve longer-lasting RI than continuous sound, and to explore its underlying neural mechanisms using EEG.
The 3 groups in the trial
- Personalized 40 Hz Broadband StimulationTreatment being tested
Participants receive personalized broadband acoustic stimulation modulated at 40 Hz. An adaptive equalization algorithm, based on individual and population residual inhibition (RI) responses, is used to weight frequency components across 125 Hz-12 kHz.
- 40 Hz Pure Tone StimulationTreatment being tested
Participants receive pure tone stimulation at the individually optimized carrier frequency identified in earlier phases, amplitude-modulated at 40 Hz.
- Continuous Broadband NoiseExisting treatment, for comparison
Participants receive continuous broadband noise stimulation without 40 Hz modulation.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Reversible Suppression of a Phantom Percept is Associated With State-dependent Cortical Network Reconfiguration
- Record updated
- 27 October 2026